Methylphenidate Hydrochloride Tablet, Extended Release
Product Images NDC 13811-700

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 13811-700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trigen Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Image (Methylphenidate HCl Extended Release Tablets 1)

FDA Label Image

Figure 1 (Methylphenidate HCl Extended Release Tablets 2)

Figure 1 (Methylphenidate HCl Extended Release Tablets 2)
Mean plasma methylphenidate concentrations (in ng/mL) are listed for two types of medication: Methylphenidate HCI extended-release tablets (18mg once daily) and Methylphenidate 5mg taken three times daily. The values are not available due to formatting issues in the output.*
FDA Label Image

Figure 2 (Methylphenidate HCl Extended Release Tablets 3)

Figure 2 (Methylphenidate HCl Extended Release Tablets 3)
The text appears to be a partial prescription for medication that includes the name of the drug (Methphenidate) and dosing instructions (one tablet per day). However, it is incomplete and does not provide enough information for safe or effective use of the medication.*
FDA Label Image

Figure 3 (Methylphenidate HCl Extended Release Tablets 4)

FDA Label Image

Trigen Logo (Methylphenidate HCl Extended Release Tablets 5)

FDA Label Image

Trigen Logo (Methylphenidate HCl Extended Release Tablets 6)

FDA Label Image

Methylphenidate 45 mg 30ct Bl 200306-1 Rev. 06/2022 (Methylphenidate HCl Extended Release Tablets 7)

Methylphenidate 45 mg 30ct Bl 200306-1 Rev. 06/2022 (Methylphenidate HCl Extended Release Tablets 7)
This package contains 30 tablets of 45mg methylphenidate hydrochloride USP, which is an extended-release medication. It is recommended to store the package at a temperature of 20-25°C and protect it from moisture and humidity. This package is child-resistant and should be kept out of reach of children. The manufacturer of the medication is Trigen Laboratories, LLC located in Alpharetta, GA 30005. A medication guide is also included with this package which should be dispensed to each patient by the pharmacist.*
FDA Label Image

Methylphenidate 63 mg 30ct Bl 200307-1 Rev. 062022 (Methylphenidate HCl Extended Release Tablets 8)

Methylphenidate 63 mg 30ct Bl 200307-1 Rev. 062022 (Methylphenidate HCl Extended Release Tablets 8)
This is a medication package containing 30 extended-release tablets, with each tablet containing 63mg of methylphenidate hydrochloride, which is equivalent to 54.5mg of methylphenidate. The usual dosage and other information are mentioned in the accompanying prescribing information. The package is child-resistant and should be stored at 20° to 25°C (68° to 77°F) with protection from moisture and humidity. The tablets should be dispensed in tight containers and kept out of reach of children. The package comes with a medication guide and is manufactured by Trigen Laboratories, LLC. The GTIN number is 00313811700305.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.